Shanghai RAAS Blood Products Co Ltd - ESG Rating & Company Profile powered by AI
The report of Shanghai RAAS Blood Products Co Ltd leverages intelligence from across the internet and also from available documents by Shanghai RAAS Blood Products Co Ltd. Other corporations in the rating peer group for Shanghai RAAS Blood Products Co Ltd are shown. The report of Shanghai RAAS Blood Products Co Ltd is assembled by All Street Sevva using leading machine learning.
Shanghai RAAS Blood Products Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Shanghai RAAS Blood Products Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shanghai RAAS Blood Products Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Shanghai RAAS Blood Products Co Ltd disclose current and historical energy intensity?
Does Shanghai RAAS Blood Products Co Ltd report the average age of the workforce?
Does Shanghai RAAS Blood Products Co Ltd reference operational or capital allocation in relation to climate change?
Does Shanghai RAAS Blood Products Co Ltd disclose its ethnicity pay gap?
Does Shanghai RAAS Blood Products Co Ltd disclose cybersecurity risks?
Does Shanghai RAAS Blood Products Co Ltd offer flexible work?
Does Shanghai RAAS Blood Products Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shanghai RAAS Blood Products Co Ltd disclose the number of employees in R&D functions?
Does Shanghai RAAS Blood Products Co Ltd conduct supply chain audits?
Does Shanghai RAAS Blood Products Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shanghai RAAS Blood Products Co Ltd conduct 360 degree staff reviews?
Does Shanghai RAAS Blood Products Co Ltd disclose the individual responsible for D&I?
Does Shanghai RAAS Blood Products Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shanghai RAAS Blood Products Co Ltd disclose current and / or historical scope 2 emissions?
Does Shanghai RAAS Blood Products Co Ltd disclose water use targets?
Does Shanghai RAAS Blood Products Co Ltd have careers partnerships with academic institutions?
Did Shanghai RAAS Blood Products Co Ltd have a product recall in the last two years?
Does Shanghai RAAS Blood Products Co Ltd disclose incidents of discrimination?
Does Shanghai RAAS Blood Products Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Shanghai RAAS Blood Products Co Ltd issued a profit warning in the past 24 months?
Does Shanghai RAAS Blood Products Co Ltd disclose parental leave metrics?
Does Shanghai RAAS Blood Products Co Ltd disclose climate scenario or pathway analysis?
Does Shanghai RAAS Blood Products Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shanghai RAAS Blood Products Co Ltd disclose the pay ratio of women to men?
Does Shanghai RAAS Blood Products Co Ltd support suppliers with sustainability related research and development?
Does Shanghai RAAS Blood Products Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shanghai RAAS Blood Products Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shanghai RAAS Blood Products Co Ltd involved in embryonic stem cell research?
Does Shanghai RAAS Blood Products Co Ltd disclose GHG and Air Emissions intensity?
Does Shanghai RAAS Blood Products Co Ltd disclose its waste policy?
Does Shanghai RAAS Blood Products Co Ltd report according to TCFD requirements?
Does Shanghai RAAS Blood Products Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shanghai RAAS Blood Products Co Ltd disclose energy use targets?
Does Shanghai RAAS Blood Products Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shanghai RAAS Blood Products Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Shanghai RAAS Blood Products Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.